For the Inventor, By the Inventor

Enter assignee name

Ottawa Hospital Research Institute

USPTO Granted Patents = 33

CIPO Patents = 61

EPO Patents = 18

Forward Citations = 142

Loading Chart...

Loading Chart...

123 inventors (with patents filed for the assignee):

John Cameron Bell (8 out of 30 patents)

Jean-Simon Diallo (6 out of 11 patents)

Michael A Rudnicki (5 out of 13 patents)

4. Fabrice Le Boeuf (4 out of 9 patents)

5. Andrew J E Seely (4 out of 4 patents)

6. Ramya Krishnan (3 out of 5 patents)

7. Rozanne Arulanandam (3 out of 7 patents)

8. David F Stojdl (3 out of 13 patents)

9. Rejean Munger (2 out of 6 patents)

10. Fabien Le Grand (2 out of 2 patents)

11. Christophe L Herry (2 out of 2 patents)

12. William L Stanford (2 out of 2 patents)

13. Neil Lagali (2 out of 3 patents)

14. Brian D Lichty (2 out of 10 patents)

15. Mohammed Selman (2 out of 2 patents)

33 patents: Sort by Forward Citations

1. 12440525 - Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses (2025-10-14),

2. 12076353 - Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses (2024-09-03),

3. 11802292 - Modified orthopoxvirus vectors (2023-10-31),

4. 11739350 - MicroRNA-based compositions and methods used in disease treatment (2023-08-29),

5. 11517598 - Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic efficacy of oncolytic RNA viruses (2022-12-06),

6. 11339448 - Treatment of acute myeloid leukemia (2022-05-24),

7. 10828346 - Compositions and methods for modulating stem cells and uses thereof (2020-11-10),

8. 10806802 - Adeno-associated virus particle with mutated capsid and methods of use thereof (2020-10-20),

9. 10654839 - Compositions and methods for viral sensitization (2020-05-19),

10. 10172569 - System and method for assisting decisions associated with events relative to withdrawal of life-sustaining therapy using variability measurements (2019-01-08),

11. 10071138 - Compositions and methods for modulating stem cells and uses thereof (2018-09-11),

12. 10002428 - Method and system for identifying bleeding (2018-06-19),

13. 9987225 - Crosslinked hydrogels and related method of preparation (2018-06-05),

14. 9962427 - Treatment of right ventricular dysfunction due to pressure overload (2018-05-08),

15. 9785745 - System and method for providing multi-organ variability decision support for extubation management (2017-10-10),

The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital, one of Canada's largest learning and research hospitals. As an affiliated research institute of the University of Ottawa, OHRI aims to make discoveries today for healthier tomorrows. With a focus on translating and applying knowledge to improve patient care, OHRI investigators are engaged in innovative research in multiple areas, including cancer therapeutics, clinical epidemiology, regenerative medicine, neuroscience, and chronic disease management.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

33 Patents

#25 in Ottawa

#383 in Canada

#19,508 in the World

Ottawa Hospital Research Institute

Forward Citations = 142

123 inventors:

John Cameron Bell (8 out of 30 patents)

Jean-Simon Diallo (6 out of 11 patents)

Michael A Rudnicki (5 out of 13 patents)

4. Fabrice Le Boeuf (4 out of 9 patents)

5. Andrew J E Seely (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…